n-methylaspartate has been researched along with s18986-1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baud, O; Destot-Wong, KD; Favrais, G; Gressens, P; Gupta, SK; Lelièvre, V; Liang, K; Mani, S; Pansiot, J; Schwendimann, L; Spedding, M | 1 |
1 other study(ies) available for n-methylaspartate and s18986-1
Article | Year |
---|---|
The AMPA receptor positive allosteric modulator, S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis.
Topics: Animals; Animals, Newborn; Apoptosis; Benzothiadiazines; Brain; Brain Diseases; Brain-Derived Neurotrophic Factor; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Female; Male; Mice; N-Methylaspartate; Necrosis; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Time Factors | 2009 |